Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MLLT3 |
| Upstream (Parents) |
|---|
| (<<) MYB → MLLT3 |
| (<<) GPSM2 → MLLT3 |
| (<<) EPHB2 → MLLT3 |
| (<<) ROD1 → MLLT3 |
| Downstream (Children) |
|---|
| MLLT3 → SPAG1 (>>) |
| MLLT3 → GALNT6 (>>) |
| MLLT3 → FAM55D (>>) |
| MLLT3 → SATB2 (>>) |
| MLLT3 → EPHB2 (>>) |
| MLLT3 → FAM83E (>>) |
| MLLT3 → ACOT11 (>>) |
| MLLT3 → P2RY2 (>>) |
| MLLT3 → GFPT1 (>>) |
| MLLT3 → HIST1H2BC///HIST1H2BI///HIST1H2BE///HIST1H2BF///HIST1H2BG (>>) |
| MLLT3 → RAG1 (>>) |
| MLLT3 → DUSP8 (>>) |
| MLLT3 → ROD1 (>>) |
| MLLT3 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI (>>) |
| MLLT3 → JUN (>>) |
